Merck Tbk (MERK) - Total Assets

Latest as of September 2025: Rp987.93 Billion IDR ≈ $57.89 Million USD

Based on the latest financial reports, Merck Tbk (MERK) holds total assets worth Rp987.93 Billion IDR (≈ $57.89 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Merck Tbk cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Merck Tbk - Total Assets Trend (2000–2024)

This chart illustrates how Merck Tbk's total assets have evolved over time, based on quarterly financial data. See shareholders equity of Merck Tbk for net asset value and shareholders' equity analysis.

Merck Tbk - Asset Composition Analysis

Current Asset Composition (December 2024)

Merck Tbk's total assets of Rp987.93 Billion consist of 74.2% current assets and 25.9% non-current assets.

Asset Category	Amount (IDR)	% of Total Assets
Cash & Equivalents	Rp0.00	9.2%
Accounts Receivable	Rp180.19 Billion	18.8%
Inventory	Rp391.92 Billion	41.0%
Property, Plant & Equipment	Rp211.90 Billion	22.1%
Intangible Assets	Rp1.89 Billion	0.2%
Goodwill	Rp0.00	0.0%

Asset Composition Trend (2000–2024)

This chart illustrates how Merck Tbk's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Merck Tbk market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Merck Tbk's current assets represent 74.2% of total assets in 2024, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 9.2% of total assets in 2024, down from 19.9% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
Asset Diversification: The largest asset category is inventory at 41.0% of total assets.

Merck Tbk Competitors by Total Assets

Key competitors of Merck Tbk based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Alkem Laboratories Limited NSE:ALKEM	India	Rs202.87 Billion
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	China	CN¥12.75 Billion
Alkermes plc F:8AK	Germany	€4.26 Billion
Jilin Aodong Pharmaceutical Group Co Ltd SHE:000623	China	CN¥35.27 Billion
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	China	CN¥6.49 Billion
Fujian Cosunter Pharmaceutical Co Ltd SHE:300436	China	CN¥1.41 Billion

Merck Tbk - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	6.76	4.53	2.55
Quick Ratio	3.79	1.70	1.36
Cash Ratio	0.00	0.00	0.00
Working Capital	Rp647.46 Billion	Rp522.16 Billion	Rp412.06 Billion

Merck Tbk - Advanced Valuation Insights

This section examines the relationship between Merck Tbk's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.63
Latest Market Cap to Assets Ratio	0.00
Asset Growth Rate (YoY)	-0.1%
Total Assets	Rp956.94 Billion
Market Capitalization	$102.38 Million USD

Valuation Analysis

Below Book Valuation: The market values Merck Tbk's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Merck Tbk's assets decreased by 0.1% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Merck Tbk (2000–2024)

The table below shows the annual total assets of Merck Tbk from 2000 to 2024.

Year	Total Assets	Change
2024-12-31	Rp956.94 Billion ≈ $56.07 Million	-0.09%
2023-12-31	Rp957.81 Billion ≈ $56.12 Million	-7.69%
2022-12-31	Rp1.04 Trillion ≈ $60.80 Million	+1.11%
2021-12-31	Rp1.03 Trillion ≈ $60.14 Million	+10.36%
2020-12-31	Rp929.90 Billion ≈ $54.49 Million	+3.20%
2019-12-31	Rp901.06 Billion ≈ $52.80 Million	-28.66%
2018-12-31	Rp1.26 Trillion ≈ $74.01 Million	+49.13%
2017-12-31	Rp847.01 Billion ≈ $49.63 Million	+13.85%
2016-12-31	Rp743.93 Billion ≈ $43.59 Million	+15.94%
2015-12-31	Rp641.65 Billion ≈ $37.60 Million	-10.46%
2014-12-31	Rp716.60 Billion ≈ $41.99 Million	+2.82%
2013-12-31	Rp696.95 Billion ≈ $40.84 Million	+22.39%
2012-12-31	Rp569.43 Billion ≈ $33.37 Million	-2.56%
2011-12-31	Rp584.39 Billion ≈ $34.24 Million	+34.41%
2010-12-31	Rp434.77 Billion ≈ $25.48 Million	+0.18%
2009-12-31	Rp433.97 Billion ≈ $25.43 Million	+15.71%
2008-12-31	Rp375.06 Billion ≈ $21.98 Million	+13.29%
2007-12-31	Rp331.06 Billion ≈ $19.40 Million	+17.11%
2006-12-31	Rp282.70 Billion ≈ $16.57 Million	+29.66%
2005-12-31	Rp218.03 Billion ≈ $12.78 Million	+8.76%
2004-12-31	Rp200.47 Billion ≈ $11.75 Million	+0.07%
2003-12-31	Rp200.33 Billion ≈ $11.74 Million	+16.24%
2002-12-31	Rp172.34 Billion ≈ $10.10 Million	+5.91%
2001-12-31	Rp162.72 Billion ≈ $9.53 Million	+25.47%
2000-12-31	Rp129.68 Billion ≈ $7.60 Million	--

About Merck Tbk

JK:MERK Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$102.38 Million

Rp1.75 Trillion IDR

Market Cap Rank

#19110 Global

#325 in Indonesia

Share Price

Rp3900.00

Change (1 day)

+0.00%

52-Week Range

Rp2790.00 - Rp4380.00

All Time High

Rp4843.89